Tag: global diabetic kidney disease market

  • 2024-2033 Diabetic Kidney Disease Market Forecast: Predicted Growth Rate and Market Size

    2024-2033 Diabetic Kidney Disease Market Forecast: Predicted Growth Rate and Market Size

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How Rapidly is the Diabetic Kidney Disease Market Forecasted to Grow Between 2024 and 2033?

    The market size of diabetic kidney disease has seen robust growth in recent years. It is projected to rise from $2.51 billion in 2023 to $2.65 billion in 2024, with a compound annual growth rate (CAGR) of 5.7%. The growth during the past years can be credited to several factors such as an improved early comprehension of diabetes-related complications, advancements in diagnostic techniques, the invention of ace inhibitors and arbs, the conduct of clinical trials, and the evolution of treatment protocols, guidelines, and disease management strategies.

    In the coming years, a significant expansion is anticipated in the diabetic kidney disease market. It is projected to reach a worth of $3.29 billion in 2028, reflecting a compound annual growth rate (CAGR) of 5.5%. The expected rise during the forecast period can be credited to factors such as the creation of personalized medicine and biomarkers, escalating worldwide diabetes occurrence, emphasis on altering disease therapies, utilization of telehealth and remote care, and adjustments in health policy and reimbursements. The forecast period is also expected to see major trends such as advancements in renal replacement therapies, the adoption of a precision medicine approach, focus on early recognition and diagnosis, progress in therapeutic methods, and increased management of comorbid conditions.

    Claim Your Free Sample of the Global Diabetic Kidney Disease Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9932&type=smp

    What Factors Are Behind the Rapid Growth of the diabetic kidney disease Market?

    The growth of the diabetic kidney disease market is likely to be driven by the escalating frequency of chronic kidney disease. Chronic kidney disease (CKD) is a lasting health issue that eventually leads to a decrease in kidney functionality, giving rise to various complications such as elevated blood pressure, anemia, and bone disorders. The need for diagnostic measures and treatment options to manage this condition boosts the growth of the diabetic kidney disease market. According to a 2021 report from the Centers for Disease Control and Prevention (CDC), a public health agency in the US, over 37 million people in the US were estimated to be living with chronic kidney disease. Additionally, CKD is prevalent in adults aged 65 and above, with about 38% of this demographic experiencing some sort of kidney damage. As such, the escalating occurrence of chronic kidney disease is a key driver for the expansion of the diabetic kidney disease market.

    What Are the Principal Segments of the Diabetic Kidney Disease Market?

    1) By Type: Type 1 Diabetes, Type 2 Diabetes

    2) By Treatment: Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments

    3) By End User: Hospitals, Homecare, Specialty Centers, Other End Users

    What Emerging Patterns Are Redefining the Diabetic Kidney Disease Market?

    Innovations in technology are becoming a significant trend in the diabetic kidney disease market. Firms within this market are utilizing new technologies to maintain their market standing. For instance, Bloom Diagnostics, a firm based in the US specializing in diagnostics and healthcare devices, introduced the Bloom Kidney Test in August 2022. This tool seamlessly integrates with the Bloom Smart System and facilitates the evaluation of kidney health by measuring cystatin C levels, a dependable marker of kidney function. The test categorizes kidney function into three broad classifications: normal, mildly decreased, and decreased. The Bloom Smart System uses cloud-based algorithms and AI technology to amalgamate test data with other pertinent health details like medical history, lifestyle, and patient symptoms.

    Order Now for Fast Delivery of Your Diabetic Kidney Disease Market Report!

    https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

    Which Geographical Regions Are Shaping the Diabetic Kidney Disease Market Growth?

    North America was the largest region in the diabetic kidney disease market in 2023. The regions covered in the diabetic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Diabetic Kidney Disease Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the diabetic kidney disease market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Diabetic Kidney Disease Market Include

    1. Diabetic Kidney Disease Market Executive Summary

    2. Diabetic Kidney Disease Market Segments

    3. Diabetic Kidney Disease Market Size And Template Market Growth Rate

    4. Key Diabetic Kidney Disease Market Trends

    5. Major Diabetic Kidney Disease Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Diabetic Kidney Disease Market

    26. Top Diabetic Kidney Disease Companies

    27. Diabetic Kidney Disease Market Opportunities And Strategies

    28. Diabetic Kidney Disease Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis On Size, Share, And Drivers Of The Diabetic Kidney Disease Market

    Comprehensive Analysis On Size, Share, And Drivers Of The Diabetic Kidney Disease Market

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    The diabetic kidney disease market has witnessed robust growth in recent years, with significant projections for the future. Let’s delve into the key factors driving this expansion and the trends shaping the landscape.

    Market Growth Trajectory

    • The diabetic kidney disease market size surged from $2.51 billion in 2023 to $2.65 billion in 2024, reflecting a Compound Annual Growth Rate (CAGR) of 5.7%.
    • Forecasts suggest continued growth, with expectations of reaching $3.29 billion in 2028, at a CAGR of 5.5%.

    Factors Driving Growth

    1. Advancements in Diagnostic Techniques and Treatment Protocols:
      • Early understanding of diabetes complications has spurred the development of diagnostic technologies.
      • ACE inhibitors and ARBs have played pivotal roles in managing diabetic kidney disease.
    2. Rising Global Diabetes Incidence:
      • The increasing prevalence of diabetes globally contributes to the expanding diabetic kidney disease market.
    3. Focus on Disease Modification Therapies:
      • Shift towards personalized medicine and biomarker development.
      • Therapies aimed at modifying the progression of diabetic kidney disease.
    4. Healthcare Policy and Reimbursement Changes:
      • Changes in healthcare policies and reimbursement schemes influence market dynamics.

    Major Trends in the Forecast Period

    • Advancements in Renal Replacement Therapies:
      • Innovations in treatments for end-stage kidney disease.
    • Precision Medicine Approach:
      • Tailoring treatments based on individual patient profiles.
    • Focus on Early Detection and Diagnosis:
      • Emphasis on identifying diabetic kidney disease at its nascent stages.
    • Rise in Comorbidities Management:
      • Addressing overlapping health conditions alongside diabetic kidney disease.

    Impact of Escalating Healthcare Expenditure

    • Boosting Market Growth:
      • Increased healthcare spending facilitates adoption of advanced diagnostic technologies.
      • Growth projections indicate rising healthcare expenditure, particularly in Medicare and Medicaid.

    Key Players in the Market

    • AstraZeneca PLC
    • Pfizer Inc.
    • Novartis AG
    • Bayer AG
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.
    • Bristol-Myers Squibb Company
    • Sun Pharmaceutical Industries Ltd.
    • Mylan NV
    • And many others.

    View More On The Diabetic Kidney Disease Market Report 2024 – 
    https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

    Technological Advancements Reshaping the Market

    • Adoption of New Technologies:
      • Companies integrate innovative solutions to maintain market relevance.
    • Example: Bloom Diagnostics’ Bloom Kidney Test:
      • Measures cystatin C levels for kidney function assessment.
      • Integrates AI technology for comprehensive patient evaluation.

    Notable Acquisition: AstraZeneca’s Acquisition of Cincor Pharma Inc.

    • AstraZeneca’s acquisition of Cincor Pharma Inc. enhances its cardiorenal pipeline.
    • CinCor’s baxdrostat (CIN-107) complements AstraZeneca’s offerings for blood pressure management in treatment-resistant hypertension.

    Market Segmentation

    1. By Type:
      • Type 1 Diabetes
      • Type 2 Diabetes
    2. By Treatment:
      • ARBs
      • ACE Inhibitors
      • Antioxidant Inflammation Modulator
      • Calcium Channel Blockers
      • Other Treatments
    3. By End User:
      • Hospitals
      • Homecare
      • Specialty Centers
      • Other End Users

    Regional Insights

    • North America emerged as the largest region in the diabetic kidney disease market in 2023.

    In conclusion, the diabetic kidney disease market is witnessing substantial growth driven by technological innovations, healthcare policies, and rising diabetes prevalence. As companies continue to invest in research and development, the market is poised for further expansion, presenting opportunities for stakeholders across the healthcare spectrum.

    Request A Sample Of The Global Diabetic Kidney Disease Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9932&type=smp